Publications

5808 Results

OV21/PETROC: A randomized Gynecologic Cancer Intergroup (GCIG) phase II study of intraperitoneal (IP) versus intravenous (IV) chemotherapy following neoadjuvant chemotherapy and optimal debulking surgery in epithelial ovarian cancer (EOC)

Authors
H Mackay;CJ Gallagher;W Parulekar;JA Ledermann;D Armstrong;C Gourley;I Romero;A Feeney;P Bessette;M Hall;JI Weberpals;G Hall;S Lau;P Gauthier;M Fung-Kee-Fung;E Eisenhauer;C Winch;D Tu;D Provencher
Journal / Conference
Journal of Clinical Oncology 34, 2016 (suppl; abstr LBA5503);American Society of Clinical Oncology Annual Meeting (June 3-7, 2016, Chicago, IL), oral
Year
2016
Research Committee(s)
Gynecologic
Study Number(s)
OV21

A Genetic Contribution to Prostate Cancer Incidence in Men of African Ancestry

Authors
CA Haiman;DV Conti;ELLIPSE GAME-ON Consortium
Journal / Conference
American Society of Human Genetics Meeting (Oct 18-22, 2016, Vancouver, BC), poster presentation
Year
2016
Research Committee(s)
Cancer Control, Prevention, Screening, and Surveillance, Prevention, Screening, and and Surveillance
Study Number(s)
S0000, SWOG-9217

Integrated analysis of multidimensional genomic data on CALGB 40601 (Alliance), a randomized neoadjuvant phase III trial of weekly paclitaxel (T) and trastuzumab (H) with or without lapatinib (L) for HER2-positive breast cancer

Authors
M Tanioka;C Fan;LA Carey;T Hyslop;B Pitcher;J Parker;K Hoadley;NL Henry;S Tolaney;C Dang;IE Krop;L Harris;DA Berry;E Mardis;E Winer;CA Hudis
Journal / Conference
San Antonio Breast Cancer Symposium (Dec 6-10, 2016, San Antonio, TX), oral, #S3-05
Year
2016
Research Committee(s)
Breast

US intergroup study of chemotherapy plus dasatinib and allogeneic stem cell transplant in Philadelphia chromosome positive ALL

Authors
F Ravandi;M Othus;S O'Brien;SJ Forman;C Ha;JYC Wong;M Tallman;E Paietta;J Racevskis;J Uy;M Horowitz;N Takebe;RF Little;UM Borate;P Kebriaei;L Kingsbury;H Kantarjian;J Radich;H Erba;F Appelbaum
Journal / Conference
Blood Advances Dec 1(3):250-259
Year
2016
Research Committee(s)
Leukemia
PMID
PMID29046900
PMC
PMC5642915
Study Number(s)
S0805

Long term efficacy and QOL data of chemohormonal therapy (C-HT) in low and high volume hormone naïve metastatic prostate cancer (PrCa): E3805 CHAARTED trial

Authors
C Sweeney;Y-H Chen;G Liu;M Carducci;D Jarrard;M Eisenberger;Y Wong;L Patrick-Miller;N Hahn;M Kohli;M Conney;R Dreicer;N Vogelzang;J Picus;D Shevrin;M Hussain;J Garcia;R Dipaola
Journal / Conference
Annals of Oncology vol. 27, 2016 Supp 6,abst. 720PD; European Society for Medical Oncology (October 7-11, 2016, Copenhagen, Denmark), (Annals of Oncology), poster
Year
2016
Research Committee(s)
Genitourinary
Study Number(s)
CTSU/E3805

Lung-MAP (S1400) Lung Master Protocol: Accrual and Genomic screening updates

Authors
V Papadimitrakopoulou;M Redman;D Gandara;F Hirsch;P Mack;H Borghaei;C Langer;J Wade;M Edelman;K Albain;P Lara;C Aggarwal;M Socinski;S Gettinger;L Bazhenova;S Malik;V Miller;S McDonough;E Sigal;K Kelly;R Herbst
Journal / Conference
World Conference on Lung Cancer (Dec 4-7, 2016,Vienna, Austria), oral
Year
2016
Research Committee(s)
Lung
Study Number(s)
S1400

Role of KRAS mutation status in NSCLC patients treated on S0819, a phase II trial of chemotherapy with or without cetuximab

Authors
P Mack;J Moon;R Herbst;ES Kim;T Semrad;M Redman;RA Tsai;L Solis;J Gregg;S Hatcher;M Varella Garcia;F Hirsch;C Blanke;K Kelly;D Gandara
Journal / Conference
World Conference on Lung Cancer (Dec 4-7, 2016,Vienna, Austria); poster
Year
2016
Research Committee(s)
Lung
Study Number(s)
S0819

Afatinib with or without cetuximab for first-line treatment of advanced EGFR-mutant NSCLC: Interim Results of SWOG S1403

Authors
S Goldberg;J Moon;R Lilenbaum;K Politi;M Melnick;T Stinchcombe;L Horn;E Chen;J Miao;M Redman;K Kelly;D Gandara
Journal / Conference
World Conference on Lung Cancer (Dec 4-7, 2016,Vienna, Austria); poster
Year
2016
Research Committee(s)
Lung
Study Number(s)
S1403

A phase II study of dasatinib and dexamethasone as primary therapy followed by hematopoietic cell transplantation for adults with Philadelphia chromosome-positive acute lymphoblastic leukemia: CALGB Study 10701 (Alliance)

Authors
MJ Wieduwilt;J Yin;M Wetzler;G Uy;BL Powell;J Kolitz;M Liedtke;W Stock;J Beumer;R Mattison;A Halvorson;S Devine;R Stone;R Larson
Journal / Conference
Blood 2016 128:2782; American Society of Hematology Annual Meeting (December 3-6, 2016, San Diego, CA), poster
Year
2016
Research Committee(s)
Leukemia
Study Number(s)
CTSU/C10701

Reply to H.J.A. Adams et al and E.A. Hawkes et al [correspondence re S0816]

Authors
O Press;J Friedberg
Journal / Conference
Journal of Clinical Oncology; DOI: 10.1200/JCO.2016.69.7979; online before print October 28, 2016
Year
2016
Research Committee(s)
Lymphoma
PMID
PMID27069074
PMC
n/a - correspondence
Study Number(s)
S0816